Feb 10 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2021 Dec 31, 2020 Dec 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 414 mln 355 mln 370 mln
(+16.5 pct) (-38.7 pct) (-10.7 pct)
Operating loss 171 mln loss 265 mln loss 690 mln
Recurring loss 159 mln loss 289 mln loss 700 mln
Net
Net loss 148 mln loss 276 mln loss 670 mln
EPS loss 5.08 yen loss 10.16 yen loss 22.82 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T